ES2151454B1 - POMADA FOR THE TREATMENT OF THE CHRONIC ANAL FISSURE AND OTHER INFLAMMATORY PROCESSES OF THE YEAR. - Google Patents

POMADA FOR THE TREATMENT OF THE CHRONIC ANAL FISSURE AND OTHER INFLAMMATORY PROCESSES OF THE YEAR.

Info

Publication number
ES2151454B1
ES2151454B1 ES9900937A ES9900937A ES2151454B1 ES 2151454 B1 ES2151454 B1 ES 2151454B1 ES 9900937 A ES9900937 A ES 9900937A ES 9900937 A ES9900937 A ES 9900937A ES 2151454 B1 ES2151454 B1 ES 2151454B1
Authority
ES
Spain
Prior art keywords
treatment
inflammatory processes
pomada
year
anal fissure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES9900937A
Other languages
Spanish (es)
Other versions
ES2151454A1 (en
Inventor
Szlec Christopher Dura
Perez Bernardo Costales
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to ES9900937A priority Critical patent/ES2151454B1/en
Publication of ES2151454A1 publication Critical patent/ES2151454A1/en
Application granted granted Critical
Publication of ES2151454B1 publication Critical patent/ES2151454B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La pomada comprende alantoína (1,5-2,5%), bálsamo del Perú (1,5-2,5%), óxido de zinc (7-10%), almidón (7-10%), lidocaína clorhidrato (1-2,5%), neomicina sulfato (0,35-0,60%), nitroglicerina (0,2-0,3%) y una mezcla de excipientes (balance). La pomada es adecuada para el tratamiento de la fisura anal crónica y otros procesos inflamatorios del ano.The ointment comprises allantoin (1.5-2.5%), balsam of Peru (1.5-2.5%), zinc oxide (7-10%), starch (7-10%), lidocaine hydrochloride ( 1-2.5%), neomycin sulfate (0.35-0.60%), nitroglycerin (0.2-0.3%) and a mixture of excipients (balance). The ointment is suitable for the treatment of chronic anal fissure and other inflammatory processes of the anus.

ES9900937A 1999-05-06 1999-05-06 POMADA FOR THE TREATMENT OF THE CHRONIC ANAL FISSURE AND OTHER INFLAMMATORY PROCESSES OF THE YEAR. Expired - Fee Related ES2151454B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9900937A ES2151454B1 (en) 1999-05-06 1999-05-06 POMADA FOR THE TREATMENT OF THE CHRONIC ANAL FISSURE AND OTHER INFLAMMATORY PROCESSES OF THE YEAR.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9900937A ES2151454B1 (en) 1999-05-06 1999-05-06 POMADA FOR THE TREATMENT OF THE CHRONIC ANAL FISSURE AND OTHER INFLAMMATORY PROCESSES OF THE YEAR.

Publications (2)

Publication Number Publication Date
ES2151454A1 ES2151454A1 (en) 2000-12-16
ES2151454B1 true ES2151454B1 (en) 2001-07-01

Family

ID=8308264

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9900937A Expired - Fee Related ES2151454B1 (en) 1999-05-06 1999-05-06 POMADA FOR THE TREATMENT OF THE CHRONIC ANAL FISSURE AND OTHER INFLAMMATORY PROCESSES OF THE YEAR.

Country Status (1)

Country Link
ES (1) ES2151454B1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3022286A (en) * 1959-12-14 1962-02-20 S B Penick And Company Process for preparing higher fatty acid salts of neomycin
NL189650C (en) * 1978-05-30 1993-06-16 Ace Veterinary Products B V PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF WOUNDS.
WO1995032715A1 (en) * 1994-05-27 1995-12-07 Neptune Pharmaceutical Corporation Nitric oxide donor composition and method for treatment of anal disorders
ES2092451B1 (en) * 1995-05-11 1997-05-16 Endoprofarma S L ENDORECTAL TOPIC APPLICATION OINTMENT FOR THE TREATMENT OF HYPERTONIA OF ANAL SPHINTER.
IT1297886B1 (en) * 1997-02-28 1999-12-20 Carmine Antropoli NIFEDIPINA FOR TOPICAL USE

Also Published As

Publication number Publication date
ES2151454A1 (en) 2000-12-16

Similar Documents

Publication Publication Date Title
BRPI0413028A (en) compound use of a compound pharmaceutical composition and pharmaceutical kit
BR9910864A (en) Anti-inflammatory compounds for inhibiting cell adhesion
DK1161248T3 (en) Pharmaceutical composition containing a source of nitrate and an acidifying agent for the treatment of open wounds and burns
ES2186746T3 (en) SORBENT COMPOSITION.
TR200100474T2 (en) Hydroxy pipekolate hydroxamic acid derivatives as MMP Inhibitors.
TR199701667T2 (en) Double-cycle amino derivatives and PGD2 antagonist containing these derivatives.
ATE266636T1 (en) BENZIMIDAZOLINONE, BENZOXAZOLINONE, BENZOPIPERAZINONE, INDANONE AND THEIR DERIVATIVES AS FACTOR XA INHIBITORS
DK0730597T3 (en) Heterocyclic esters of rapamycin and their pharmaceutical preparations
BRPI0513944A (en) substantially pure form of a quinazoline compound, use of a quinazoline compound and composition
ATE368652T1 (en) NITROZED AND NITROSYLATED ALPHA-ADRENORECEPTOR ANTAGONISTS, PREPARATIONS AND USES THEREOF
MX9505182A (en) Therapeutical composition for topical application, containing a p substance antagonist.
NO20052529L (en) Compound and composition, and use of the same
BRPI0009448B8 (en) kit for use in treating a neoplasm in a mammal
DK1735296T3 (en) Materials and methods for treating coagulation disorders
DK0589703T3 (en) Proline derivatives of rapamycin, preparation and use thereof
TR199802769T2 (en) Topical composition containing a combination of terpenoid compounds and antihistamine compounds.
ATE303384T1 (en) 1-BIARYL-1,8-NAPHTHYRIDINE-4-ONE AS PHOSPHODIESETERASE INHIBITORS
SE9802794D0 (en) New compounds
DK1363876T3 (en) Glucocorticoid receptor modulators
SE9802793D0 (en) New compounds
AR034071A1 (en) ANTINEOPLASIC COMBINATIONS
ES2151454B1 (en) POMADA FOR THE TREATMENT OF THE CHRONIC ANAL FISSURE AND OTHER INFLAMMATORY PROCESSES OF THE YEAR.
CO4970744A1 (en) DANDRUFFS AND APOPTOSIS
TR200103004T2 (en) Pyrrolidincarbonylamino cyclic disulfides.
TR200201249T2 (en) The heteroatom intervening analogues of 15-hydroxyiecosatetraenoic acid and their methods of use.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20001216

Kind code of ref document: A1

Effective date: 20001216

FD1A Patent lapsed

Effective date: 20100528